These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15846078)
41. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Kinsey M; Smith R; Lessnick SL Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343 [TBL] [Abstract][Full Text] [Related]
42. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors. Desmaze C; Brizard F; Turc-Carel C; Melot T; Delattre O; Thomas G; Aurias A Cancer Genet Cytogenet; 1997 Aug; 97(1):12-9. PubMed ID: 9242212 [TBL] [Abstract][Full Text] [Related]
43. EWS-FLI1 positively regulates autophagy by increasing ATG4B expression in Ewing sarcoma cells. Lu Q; Zhang Y; Ma L; Li D; Li M; Li J; Liu P Int J Mol Med; 2017 Oct; 40(4):1217-1225. PubMed ID: 28902354 [TBL] [Abstract][Full Text] [Related]
44. Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers. Mitra P; Eckenrode JM; Mandal A; Jha AK; Salem SM; Leggas M; Rohr J J Med Chem; 2018 Sep; 61(17):8001-8016. PubMed ID: 30114371 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. Toub N; Bertrand JR; Tamaddon A; Elhamess H; Hillaireau H; Maksimenko A; Maccario J; Malvy C; Fattal E; Couvreur P Pharm Res; 2006 May; 23(5):892-900. PubMed ID: 16715379 [TBL] [Abstract][Full Text] [Related]
46. Ewing tumor biology: perspectives for innovative treatment approaches. Kovar H Adv Exp Med Biol; 2003; 532():27-37. PubMed ID: 12908547 [TBL] [Abstract][Full Text] [Related]
47. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma. Camões MJ; Paulo P; Ribeiro FR; Barros-Silva JD; Almeida M; Costa VL; Cerveira N; Skotheim RI; Lothe RA; Henrique R; Jerónimo C; Teixeira MR PLoS One; 2012; 7(11):e49819. PubMed ID: 23185447 [TBL] [Abstract][Full Text] [Related]
48. Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo. Aryee DN; Kreppel M; Bachmaier R; Uren A; Muehlbacher K; Wagner S; Breiteneder H; Ban J; Toretsky JA; Kovar H Cancer Res; 2006 Oct; 66(20):9862-9. PubMed ID: 17047047 [TBL] [Abstract][Full Text] [Related]
53. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model. Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560 [TBL] [Abstract][Full Text] [Related]
54. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma. Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378 [TBL] [Abstract][Full Text] [Related]
55. Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors. Tanaka M; Yamazaki Y; Kanno Y; Igarashi K; Aisaki K; Kanno J; Nakamura T J Clin Invest; 2014 Jul; 124(7):3061-74. PubMed ID: 24911143 [TBL] [Abstract][Full Text] [Related]
56. Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth. Johnson KM; Mahler NR; Saund RS; Theisen ER; Taslim C; Callender NW; Crow JC; Miller KR; Lessnick SL Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9870-9875. PubMed ID: 28847958 [TBL] [Abstract][Full Text] [Related]
57. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival. Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699 [TBL] [Abstract][Full Text] [Related]
58. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma. Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833 [TBL] [Abstract][Full Text] [Related]
59. Functional analysis of the EWS/ETS target gene uridine phosphorylase. Deneen B; Hamidi H; Denny CT Cancer Res; 2003 Jul; 63(14):4268-74. PubMed ID: 12874036 [TBL] [Abstract][Full Text] [Related]